ZHONGZHIPHARM (03737) Schedules 26 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

Mar 16

Zhongzhi Pharmaceutical Holdings Limited will convene its board of directors at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Sing Road, Tsuen Wan, New Territories, Hong Kong, on Thursday, 26 March 2026.

The agenda includes: 1. Review and approval of the audited annual results for the financial year ended 31 December 2025. 2. Deliberation on the payment of a final dividend for FY2025, if any.

As of the announcement date (16 March 2026), the Board comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, and Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia), and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, and Mr. Zhou Dai Han).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1169102235"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169102235\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169102235?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169102235","market":"us","top_or_hot":-1,"title":"ZHONGZHIPHARM (03737) Schedules 26 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Zhongzhi Pharmaceutical Holdings Limited will convene its board of directors at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Sing Road, Tsuen Wan, New Territories, Hong Kong, on Thursday, 26 March 2026.</p>\n<p>The agenda includes:  \n1. Review and approval of the audited annual results for the financial year ended 31 December 2025.  \n2. Deliberation on the payment of a final dividend for FY2025, if any.</p>\n<p>As of the announcement date (16 March 2026), the Board comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, and Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia), and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, and Mr. Zhou Dai Han).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZHONGZHIPHARM (03737) Schedules 26 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZHONGZHIPHARM (03737) Schedules 26 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 17:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhongzhi Pharmaceutical Holdings Limited will convene its board of directors at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Sing Road, Tsuen Wan, New Territories, Hong Kong, on Thursday, 26 March 2026.</p>\n<p>The agenda includes:  \n1. Review and approval of the audited annual results for the financial year ended 31 December 2025.  \n2. Deliberation on the payment of a final dividend for FY2025, if any.</p>\n<p>As of the announcement date (16 March 2026), the Board comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, and Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia), and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, and Mr. Zhou Dai Han).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03737","symbol_name":"中智药业","start_time":0,"source_url":"","article_id":"1169102235","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169102235","pubTimestamp":1773652864,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhongzhi Pharmaceutical Holdings Limited will convene its board of directors at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Sing Road, Tsuen Wan, New Territories, Hong Kong, on Thursday, 26 March 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03737":"中智药业"},"translate_title":"中智药业(03737)定于2026年3月26日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03737":1},"content_text":"Zhongzhi Pharmaceutical Holdings Limited will convene its board of directors at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Sing Road, Tsuen Wan, New Territories, Hong Kong, on Thursday, 26 March 2026.\nThe agenda includes:  \n1. Review and approval of the audited annual results for the financial year ended 31 December 2025.  \n2. Deliberation on the payment of a final dividend for FY2025, if any.\nAs of the announcement date (16 March 2026), the Board comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, and Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia), and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, and Mr. Zhou Dai Han).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}